The Clinical, Humanistic, and Economic Burden of Idiopathic Hypersomnia in the United States: Analysis of the National Health and Wellness Survey [PDF]
Caroleen Drachenberg,1 M Janelle Cambron-Mellott,2 Lin Yang,2 Bridget L Balkaran,2 Marisa Whalen,3 David T Plante4 1Global Value & HEOR, Jazz Pharmaceuticals, Palo Alto, CA, USA; 2Oracle Life Sciences, Oracle Corporation, Austin, TX, USA; 3US Medical
Drachenberg C +5 more
doaj +2 more sources
The Clinical and Economic Burden of Idiopathic Hypersomnia: Results from the Real-World Idiopathic Hypersomnia Total Health Model (RHYTHM) Study [PDF]
Ragy Saad,1 Sarah C Markt,1 Prasheel Lillaney,1 Deb A Profant,1 Douglas S Fuller,2 Elizabeth M Poole,1 Trevor Alvord,3 Patricia Prince,3 Shaina Desai,3 Marisa Whalen,2 Weiyi Ni,1 Jed Black1,4 1Jazz Pharmaceuticals, Palo Alto, CA, USA; 2Jazz ...
Saad R +11 more
doaj +2 more sources
Symptom Severity and Treatment Satisfaction in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE) [PDF]
Logan Douglas Schneider,1 Joanne Stevens,2 Aatif M Husain,3 Diane Ito,4 Douglas S Fuller,5 Phyllis C Zee,6 Wayne Macfadden2 1Stanford University Sleep Medicine Center, Stanford University School of Medicine, Stanford, CA, USA; 2Global Medical Affairs ...
Schneider LD +6 more
doaj +2 more sources
Content Validity and Psychometric Evaluation of the Idiopathic Hypersomnia Severity Scale (IHSS) in Adults with Idiopathic Hypersomnia [PDF]
Junji Lin,1 Caitlyn Lowe,2 Benjamin Banderas,2 Patricia Chandler,1 Ethan Arenson,2 Alan L Shields,2 Susan Morris,1 Bhavini Srivastava,1 Yves Dauvilliers3,4 1Jazz Pharmaceuticals, Palo Alto, CA, USA; 2Adelphi Values, Boston, MA, USA; 3Sleep and Wake ...
Lin J +8 more
doaj +2 more sources
Hyperactivity in patients with narcolepsy and idiopathic hypersomnia: an exploratory study [PDF]
Introduction Patients with either Idiopathic Hypersomnia or Narcolepsy demonstrate excessive daytime somnolence (EDS) with resultant inattention mimicking Attention Deficit Hyperactivity Disorder (ADHD).
Caroline Dodson +8 more
doaj +2 more sources
The Clinical and Economic Burden of Idiopathic Hypersomnia and Narcolepsy: A United States Claims-Based Analysis [PDF]
Ragy Saad,1 Sarah C Markt,1 Prasheel Lillaney,1 Deb A Profant,1 Douglas S Fuller,2 Elizabeth M Poole,1 Trevor Alvord,3 Patricia Prince,3 Shaina Desai,3 Marisa Whalen,2 Weiyi Ni,1 Jed Black1,4 1Jazz Pharmaceuticals, Palo Alto, CA, USA; 2Jazz ...
Saad R +11 more
doaj +2 more sources
Impairment in Functioning and Quality of Life in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE) [PDF]
Joanne Stevens,1 Logan D Schneider,2 Aatif M Husain,3 Diane Ito,4 Douglas S Fuller,5 Phyllis C Zee,6 Wayne Macfadden1 1Global Medical Affairs, Jazz Pharmaceuticals, Philadelphia, PA, USA; 2Stanford University Sleep Medicine Center, Stanford University ...
Stevens J +6 more
doaj +2 more sources
Circadian Modulation of Sleep-Wake Behavior in Patients with Narcolepsy Type 1 and Idiopathic Hypersomnia [PDF]
Franziska Ryser,1,* Ann-Sophie Windirsch,2,3,* Christian R Baumann,3,4 Olivier Lambercy,1 Roger Gassert,1 Esther Werth3,4 1Rehabilitation Engineering Laboratory, Department of Health Sciences and Technology, ETH Zurich, Zurich ...
Ryser F +5 more
doaj +2 more sources
A Patient-centric Clinical Trial Design to Comprehensively Evaluate Low-Sodium Oxybate in People with Idiopathic Hypersomnia or Narcolepsy [PDF]
Introduction Low-sodium oxybate (LXB; Xywav®) is approved to treat idiopathic hypersomnia in adults and excessive daytime sleepiness or cataplexy in individuals aged ≥ 7 years with narcolepsy.
Deborah A. Nichols +8 more
doaj +2 more sources
Treatment of idiopathic hypersomnia with modafinil in an individual at clinical high risk for psychosis: A case report [PDF]
Background Recent studies have shown that sleep disturbances are frequent at different stages of psychosis, including clinical high risk for psychosis (CHR‐P). However, the comorbidity of hypersomnia with CHR‐P and its treatment have rarely been reported
Yutaro Sato +2 more
doaj +2 more sources

